Background The effect of single as compared with dual antiplatelet treatment on bleeding
and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients …

Background The roles of anticoagulation alone or with an antiplatelet agent after
transcatheter aortic-valve implantation (TAVI) have not been well studied. Methods We …

Background Despite improving experience and techniques, ischemic and bleeding
complications after transcatheter aortic valve implantation (TAVI) remain prevalent and …

Objectives: The aim of this study was to compare aspirin plus clopidogrel with aspirin alone
as antithrombotic treatment following transcatheter aortic valve replacement (TAVR) for the …

Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is a widely accepted strategy
in patients undergoing transcatheter aortic valve implantation (TAVI), but this approach is not …

Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic alternative for
patients with symptomatic aortic stenosis at high or prohibitive surgical risk. However …

Dual antiplatelet therapy is commonly used in patients undergoing transcatheter aortic valve
implantation (TAVI), but the optimal antiplatelet regimen is uncertain and remains to be …

Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

To compare dual antiplatelet therapy (DAPT) versus single antiplatelet therapy (SAPT) as
antithrombotic treatment after transcatheter aortic valve implantation (TAVI) for the …

Background Common clinical practice recommends dual antiplatelet therapy (DAPT) for
transcatheter aortic valve implantation (TAVI). The aim of the study was to evaluate, in a …